117 related articles for article (PubMed ID: 9556575)
1. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2.
Saunders DN; Buttigieg KM; Gould A; McPhun V; Baker MS
J Biol Chem; 1998 May; 273(18):10965-71. PubMed ID: 9556575
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
[TBL] [Abstract][Full Text] [Related]
4. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides.
Muehlenweg B; Guthaus E; de Prada NA; Schmitt M; Schmiedeberg N; Kotzsch M; Creutzburg S; Kramer MD; Kessler H; Wilhelm OG; Magdolen V
Thromb Res; 2000 Apr; 98(1):73-81. PubMed ID: 10706935
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.
Wind T; Jensen MA; Andreasen PA
Eur J Biochem; 2001 Feb; 268(4):1095-106. PubMed ID: 11179976
[TBL] [Abstract][Full Text] [Related]
7. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA
Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229
[TBL] [Abstract][Full Text] [Related]
8. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
[TBL] [Abstract][Full Text] [Related]
9. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
Egelund R; Petersen TE; Andreasen PA
Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
[TBL] [Abstract][Full Text] [Related]
10. Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop.
Debrock S; Declerck PJ
Thromb Haemost; 1998 Mar; 79(3):597-601. PubMed ID: 9531048
[TBL] [Abstract][Full Text] [Related]
11. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition.
Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
J Biol Chem; 1994 Nov; 269(44):27657-62. PubMed ID: 7961684
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms.
Debrock S; Declerck PJ
Biochim Biophys Acta; 1997 Feb; 1337(2):257-66. PubMed ID: 9048903
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
[TBL] [Abstract][Full Text] [Related]
14. The localization of the relaxed form of plasminogen activator inhibitor type 2 in human gingival tissues.
Lindberg P; Baker MS; Kinnby B
Histochem Cell Biol; 2001 Nov; 116(5):447-52. PubMed ID: 11735008
[TBL] [Abstract][Full Text] [Related]
15. Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1.
Gils A; Declerck PJ
J Biol Chem; 1997 May; 272(19):12662-6. PubMed ID: 9139722
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
Kvassman JO; Verhamme I; Shore JD
Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
[TBL] [Abstract][Full Text] [Related]
17. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
[TBL] [Abstract][Full Text] [Related]
18. The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations.
Wilczynska M; Lobov S; Ny T
FEBS Lett; 2003 Feb; 537(1-3):11-6. PubMed ID: 12606023
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
Mikus P; Urano T; Liljeström P; Ny T
Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
[TBL] [Abstract][Full Text] [Related]
20. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
